Similar articles

• Factors related to completeness of medical abortion with mifepristone and misoprostol.

  Jiang WX, He FF, Shen Q, Tao XJ, Zhao CC, Shen ZJ, Zhu XQ. Jiang WX, et al. J Chin Med Assoc. 2017 Feb;80(2):96-102. doi: 10.1016/j.jcma.2016.03.011. Epub 2016 Aug 30. J Chin Med Assoc. 2017. PMID: 27591155
• Abortion and maternal mortality in Africa.

  Thonneau P, Goyaux N, Goufodji S, Sundby J. Thonneau P, et al. N Engl J Med. 2002 Dec 12;347(24):1984-5. doi: 10.1056/NEJM200212123472420. N Engl J Med. 2002. PMID: 12477956 No abstract available.
• Abortion-related mortality in a tertiary medical centre in Enugu, Nigeria.

  Nwogu-Ikojo EE, Ezegwui HU. Nwogu-Ikojo EE, et al. J Obstet Gynaecol. 2007 Nov;27(8):835-7. doi: 10.1080/01443610701718883. J Obstet Gynaecol. 2007. PMID: 18097907
• Improving technologies to reduce abortion-related morbidity and mortality.

  Rogo K. Rogo K. Int J Gynaecol Obstet. 2004 Jun;85 Suppl 1:S73-82. doi: 10.1016/j.ijgo.2004.02.010. Int J Gynaecol Obstet. 2004. PMID: 15147856 Review.
• Termination of pregnancy and unsafe abortion.

  Lim LM, Singh K. Lim LM, et al. Best Pract Res Clin Obstet Gynaecol. 2014 Aug;28(6):859-69. doi: 10.1016/j.bpobgyn.2014.05.005. Epub 2014 Jun 4. Best Pract Res Clin Obstet Gynaecol. 2014. PMID: 24962349 Review.